Abstract
Lung cancer is the most frequent cause of superior vena cava (SVC) syndrome. Malignant SVC syndrome is generally considered a contraindication to curative resection, although palliative bypasses are done for symptoms that do not respond to medical therapy. However, a majority of patients with such advanced disease die of complications caused by the primary tumor rather than distant metastasis. We present the case of one patient with lung cancer invading the mediastinal structures. Combined resection and replacement of the SVC with a segment of Dacron vascular graft was performed. Postoperative survival time was 24 months.
MeSH terms
-
Anastomosis, Surgical
-
Biocompatible Materials
-
Biopsy
-
Blood Vessel Prosthesis Implantation / methods*
-
Brachiocephalic Veins / surgery*
-
Carcinoma, Squamous Cell / complications*
-
Carcinoma, Squamous Cell / diagnostic imaging
-
Carcinoma, Squamous Cell / pathology
-
Contraindications
-
Heart Atria / surgery*
-
Humans
-
Lung Neoplasms / complications*
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / pathology
-
Male
-
Middle Aged
-
Palliative Care / methods
-
Pneumonectomy
-
Polyethylene Terephthalates
-
Superior Vena Cava Syndrome / diagnosis
-
Superior Vena Cava Syndrome / etiology*
-
Superior Vena Cava Syndrome / surgery
-
Tomography, X-Ray Computed
Substances
-
Biocompatible Materials
-
Polyethylene Terephthalates